Послеоперационная профилактика рецидива узлового эутиреоидного зоба
https://doi.org/10.14341/2306-3513-2011-1-17-20
Аннотация
Список литературы
1. Hintze G., Emrich D., Kцbberling J. Treatment of endemic goitre due to iodine deficiency with iodine, levothyroxine or both: results of a multicentre trial. Eur. J. Clin. Invest. 1992; 19: 527–534.
2. Gärtner R., Greil W., Demharter R., Horn K. Involvement of cyclic AMP, iodide and metabolites of arachidonic acid in the regulation of cell proliferation of isolated porcine thyroid follicles. Molec. Cell. Endocr. 1985; 42:145–155.
3. Laurberg P., Nyhr S.B., Pedersen K.M. et al. Thyroid disorders in mild iodine deficiency. Thyroid 2000; 10: 951–963.
4. Carella C., Mazziotti G., Rotondi M. et al. Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin. Endocr. (Oxf.) 2002; 57.
5. Feldkamp J., Seppel T., Becker A. et al. Iodide or L-thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. Wld J. Surg. 1997; 21: 10–14.
6. Rotondi M., Amato G., Del Buono A. et al. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency. Thyroid 2000; 10: 1081–1085.
7. Schumm-Draeger P.M., Encke A., Usadel K.H. Optimal recurrence prevention of iodine deficiency related goiter after thyroid gland operation. A prospective clinical study. Internist (Berl.) 2003; 44: 420–426, 429–432.
Рецензия
Для цитирования:
., ., ., . Послеоперационная профилактика рецидива узлового эутиреоидного зоба. Эндокринная хирургия. 2011;5(1):17-20. https://doi.org/10.14341/2306-3513-2011-1-17-20
For citation:
Vanushko V.E., Beltsevitch D.G., Kuznetsov N.S., Fadeev V.V. Postoperative prevention of euthyroid nodular goitre recurrence. Endocrine Surgery. 2011;5(1):17-20. (In Russ.) https://doi.org/10.14341/2306-3513-2011-1-17-20
Просмотров: 261
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Послать статью по эл. почте 
